8.55am - 4:00pm
Physical Event | Eastern Time
Physical Event | Eastern Time
8:55 am Chair’s Opening Remarks
Developing Cryopreservation Processes to Advance Logisitics
9:00 am Panel: Evaluating Whether the Use of Fresh or Frozen Leukapheresis is More Beneficial
Synopsis
• Evaluating the pros and cons of using fresh or frozen Leukapheresis
• Assessing whether the use of fresh Leukapheresis is sustainable as patient numbers grows
• Looking at emerging technologies that have promise in short-term storage of Leukapheresis
• Analyzing the impact of fresh and frozen Leukapheresis on process performance and quality attributes of final product
• Understanding the different responses of cell subsets in Leukapheresis to cryopreservation
10:00 am Where is Cold Chain Innovation Particularly Needed for Emerging Cell Therapies?
Synopsis
• Identifying new technologies to advance the cold chain of cell therapies
• Implementing novel systems in cryogenic storage for securing the self-life of cell products
• Streamlining the cryopreservation process to increase flexibility and robustness
• Establishing best practices for cryopreserving, storing, shipping and thawing of cells
10:30 am Morning refreshments & Networking
Preparing for Future Needs to Achieve Efficient Upscaling
11:30 am Discussion Session: Points to Consider in Moving Through the Development Pipeline
Synopsis
• Partnership model options
• Development strategy and investment timing – how this shapes the future
• Lessons from recent launches
12:00 pm Ensuring Consistent Supply Procurement Throughout the Upscaling of Cell Therapy
Synopsis
• Understanding the future supply demands created by growth of cell therapies
• Securing resources to cater for high volumes of individual manufacturing
• Creating a supply ecosystem that allows small and large companies to occupy
the same space
12:30pm Lunch Break & Networking
1:30 pm Preparing a Patient Operations Environment to Cater for Increased Apheresis Demands
Synopsis
• Recognizing the need for staff resource expansion to provide comprehensive
care for patients
• Increasing capacity in advance of increased demand to satisfy individual
customer needs
• Executing a robust scheduling system to manage higher patient numbers whilst
maintaining chain of identity
2:00 pm Expanding Infrastructure to Aid Global Availability of Cell Therapies
Synopsis
• Securing reliable supplies in all locations to prevent inequalities in treatment
• Accepting the need for cryopreservation storage and shipping facilities prior to onboarding novel therapy locations
• Establishing patient center locations with good transport links to simplify
logistical needs
2:30pm Afternoon Refreshments and Networking
Learning from Covid to Secure a Robust Supply Chain Ecosystem in the Future
3:00 pm Panel: Applying Lessons Learned During Covid to Reinforce the Supply Chain
Synopsis
• Preparing for decreases in supply to avoid donor cell waste
• Understanding the implications of shortages to prepare for future logistical challenges
• Appreciating the positive outcomes of Covid and employing consequent risk mitigation plans
3:30 pm Implementing Risk Management Strategies to Enforce Robustness in the Supply Chain
Synopsis
• Keeping up to date with Covid-related changes in country-specific regulations to allow continuous import
• Increasing supply chain flexibility to eliminate dependency on scheduled events
• Learning from Covid-induced challenges to build a strong strategy moving
forward